Skip to main content
logo
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
52.06
+1.07 (2.10%)
At close: Apr 28, 2026, 4:00 PM EDT
51.51
-0.55 (-1.06%)
Pre-market: Apr 29, 2026, 4:57 AM EDT

CRISPR Therapeutics AG Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Grant
3.51M3.34M3.05M2.68M2.31M2.83M2.23M1.71M
Grant Growth
51.69%17.96%36.96%56.43%91.87%---
Collaboration
----35.00M---
Collaboration Growth
-----90.54%---

Operating Expense Breakdown

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Research and Development
284.81M283.44M306.69M316.96M320.65M333.64M342.18M363.57M
Research and Development Growth
-11.18%-15.05%-10.37%-12.82%-17.22%-15.69%-18.85%-17.99%
Collaboration
213.48M170.19M124.23M131.21M120.67M130.25M142.52M135.02M
Collaboration Growth
76.92%30.67%-12.83%-2.82%-7.36%11.26%7.55%10.86%
General and Administrative
73.54M73.27M73.76M74.32M72.98M71.33M72.20M71.76M
General and Administrative Growth
0.77%2.71%2.15%3.57%-4.18%-11.77%-19.38%-25.88%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.